Immediate Impact
71 standout
Citing Papers
Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
2025 Standout
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
2025 Standout
Works of A. Köchling being referenced
RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life
2002
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A. Köchling | 146 | 88 | 104 | 124 | 19 | 362 | |
| Eri Oyanagi | 145 | 26 | 130 | 102 | 25 | 398 | |
| Roxana Carbó | 127 | 42 | 104 | 80 | 24 | 350 | |
| Carlos Ferreiro | 97 | 163 | 75 | 73 | 12 | 374 | |
| Ravindra K. Sharma | 124 | 71 | 91 | 29 | 22 | 394 | |
| Zhenzhen Cao | 111 | 36 | 62 | 59 | 19 | 369 | |
| Federica Centofanti | 152 | 39 | 55 | 39 | 21 | 364 | |
| Christine Rossmann | 107 | 80 | 42 | 58 | 18 | 339 | |
| M. C. Osterheld | 119 | 79 | 90 | 33 | 14 | 337 | |
| Shengrong Wan | 122 | 38 | 79 | 78 | 16 | 357 | |
| K. Ishii | 134 | 107 | 57 | 65 | 21 | 377 |
All Works
Loading papers...